C19orf81
gene geneOn this page
Summary
C19orf81 (chromosome 19 open reading frame 81, HGNC:40041) is a protein-coding gene on chromosome 19q13.33, encoding Putative uncharacterized protein C19orf81 (C9J6K1).
At a glance
- Clinical variants (ClinVar): 4 total
- MANE Select transcript:
NM_001195076
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:40041 |
| Approved symbol | C19orf81 |
| Name | chromosome 19 open reading frame 81 |
| Location | 19q13.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000235034 |
| Ensembl biotype | protein_coding |
| Entrez | 342918 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000425202, ENST00000458538, ENST00000490451, ENST00000850964, ENST00000850965
RefSeq mRNA: 1 — MANE Select: NM_001195076
NM_001195076
CCDS: CCDS54296
Canonical transcript exons
ENST00000425202 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001656328 | 50656226 | 50656346 |
| ENSE00001730060 | 50657989 | 50658128 |
| ENSE00001786467 | 50658947 | 50659306 |
| ENSE00003562376 | 50656050 | 50656122 |
| ENSE00004283049 | 50649445 | 50649511 |
Expression profiles
Bgee: expression breadth ubiquitous, 144 present calls, max score 79.87.
FANTOM5 (CAGE): breadth broad, TPM avg 1.0803 / max 29.4849, expressed in 488 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 177161 | 0.8945 | 456 |
| 177162 | 0.1858 | 106 |
Top tissues by expression
248 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| adenohypophysis | UBERON:0002196 | 79.87 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 79.06 | gold quality |
| cerebellar cortex | UBERON:0002129 | 78.48 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 78.31 | gold quality |
| pituitary gland | UBERON:0000007 | 78.03 | gold quality |
| pancreatic ductal cell | CL:0002079 | 77.78 | silver quality |
| cerebellum | UBERON:0002037 | 77.01 | gold quality |
| left testis | UBERON:0004533 | 73.97 | gold quality |
| right testis | UBERON:0004534 | 72.84 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 72.06 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 71.87 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 71.48 | gold quality |
| stromal cell of endometrium | CL:0002255 | 71.17 | gold quality |
| testis | UBERON:0000473 | 70.82 | gold quality |
| right uterine tube | UBERON:0001302 | 70.54 | gold quality |
| spinal cord | UBERON:0002240 | 69.25 | gold quality |
| right frontal lobe | UBERON:0002810 | 68.75 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 68.49 | gold quality |
| left adrenal gland | UBERON:0001234 | 68.21 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 68.20 | gold quality |
| cerebellar vermis | UBERON:0004720 | 68.08 | gold quality |
| putamen | UBERON:0001874 | 67.75 | gold quality |
| amygdala | UBERON:0001876 | 67.30 | gold quality |
| nucleus accumbens | UBERON:0001882 | 66.14 | gold quality |
| hypothalamus | UBERON:0001898 | 66.09 | gold quality |
| right adrenal gland | UBERON:0001233 | 66.08 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 65.84 | gold quality |
| prefrontal cortex | UBERON:0000451 | 65.60 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 65.35 | gold quality |
| adrenal cortex | UBERON:0001235 | 65.34 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.82 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
3 targeting C19orf81, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6783-3P | 99.89 | 67.92 | 2059 |
| HSA-MIR-6750-3P | 96.79 | 67.50 | 740 |
| HSA-MIR-6784-5P | 84.56 | 60.91 | 126 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | 1700008O03Rik | ENSMUSG00000008028 |
| rattus_norvegicus | C1h19orf81 | ENSRNOG00000037298 |
Protein
Protein identifiers
Putative uncharacterized protein C19orf81 — C9J6K1 (reviewed: C9J6K1)
All UniProt accessions (2): C9J6K1, H7BZS0
RefSeq proteins (1): NP_001182005* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031746 | DUF4732 | Family |
Pfam: PF15876
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-C9J6K1-F1 | 80.45 | 0.53 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 25 (showing top):
ASH1L_TARGET_GENES, BCL6B_TARGET_GENES, CEBPZ_TARGET_GENES, DIDO1_TARGET_GENES, E2F5_TARGET_GENES, EBNA1BP2_TARGET_GENES, PRKDC_TARGET_GENES, ZNF197_TARGET_GENES, ZNF528_TARGET_GENES, GSE13229_IMM_VS_INTMATURE_NKCELL_UP, MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP, DESCARTES_FETAL_MUSCLE_SKELETAL_MUSCLE_CELLS, CDC73_TARGET_GENES, GSE27786_CD4_VS_CD8_TCELL_UP, GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_UP
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
70 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C19orf81 | CXorf58 | Q96LI9 | 771 |
| C19orf81 | AXDND1 | Q5T1B0 | 583 |
| C19orf81 | BTBD17 | A6NE02 | 541 |
| C19orf81 | SYT3 | Q9BQG1 | 530 |
| C19orf81 | TMEM178B | H3BS89 | 507 |
| C19orf81 | CIMIP1 | Q9H1P6 | 475 |
| C19orf81 | KIF19 | Q2TAC6 | 447 |
| C19orf81 | BRINP2 | Q9C0B6 | 446 |
| C19orf81 | CFAP46 | Q8IYW2 | 446 |
| C19orf81 | PCDHB15 | Q9Y5E8 | 418 |
| C19orf81 | PCDHA10 | Q9Y5I2 | 393 |
| C19orf81 | TRPC7 | Q9HCX4 | 376 |
| C19orf81 | LRRC4B | Q9NT99 | 370 |
| C19orf81 | TEX261 | Q6UWH6 | 349 |
| C19orf81 | SLC25A52 | Q3SY17 | 324 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: C5IY48, C9J6K1, D3Z070, D3ZEF4, D3ZKV9, O14187, P03118, P03121, P03122, P03123, P03177, P03261, P04495, P07296, P11299, P11329, P22155, P22156, P25482, P27552, P36778, P36779, P36781, P36785, P36789, P36793, P50768, P50769, P50771, P50772, Q07849, Q07850, Q07851, Q14999, Q1HVD1, Q3KSQ2, Q5R4R7, Q5RCJ3, Q6UDH3, Q705F3
Diamond homologs: C9J6K1, D3Z070
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
4 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 3 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
470 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:50656118:TCCTC:T | donor_gain | 1.0000 |
| 19:50656121:TC:T | donor_gain | 1.0000 |
| 19:50656123:G:GG | donor_gain | 1.0000 |
| 19:50656221:CCTA:C | acceptor_loss | 1.0000 |
| 19:50656223:TA:T | acceptor_loss | 1.0000 |
| 19:50656224:A:AG | acceptor_gain | 1.0000 |
| 19:50656224:A:C | acceptor_loss | 1.0000 |
| 19:50656225:G:GA | acceptor_gain | 1.0000 |
| 19:50656225:G:T | acceptor_loss | 1.0000 |
| 19:50656225:GA:G | acceptor_gain | 1.0000 |
| 19:50656225:GAAA:G | acceptor_gain | 1.0000 |
| 19:50656292:G:GT | donor_gain | 1.0000 |
| 19:50656342:CCTTG:C | donor_gain | 1.0000 |
| 19:50656343:CTTG:C | donor_gain | 1.0000 |
| 19:50656344:TTG:T | donor_gain | 1.0000 |
| 19:50656345:TG:T | donor_gain | 1.0000 |
| 19:50656346:GG:G | donor_gain | 1.0000 |
| 19:50656347:G:GG | donor_gain | 1.0000 |
| 19:50656348:T:A | donor_loss | 1.0000 |
| 19:50657984:CGCA:C | acceptor_loss | 1.0000 |
| 19:50657985:GCA:G | acceptor_loss | 1.0000 |
| 19:50657986:CAGC:C | acceptor_loss | 1.0000 |
| 19:50657987:A:AG | acceptor_gain | 1.0000 |
| 19:50657987:AGCCC:A | acceptor_gain | 1.0000 |
| 19:50657988:G:GA | acceptor_gain | 1.0000 |
| 19:50657988:GCCC:G | acceptor_gain | 1.0000 |
| 19:50657988:GCCCG:G | acceptor_gain | 1.0000 |
| 19:50658125:ACCG:A | donor_gain | 1.0000 |
| 19:50658129:G:GG | donor_gain | 1.0000 |
| 19:50658130:T:G | donor_loss | 1.0000 |
AlphaMissense
1279 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:50658948:T:A | W135R | 0.997 |
| 19:50658948:T:C | W135R | 0.997 |
| 19:50658950:G:C | W135C | 0.994 |
| 19:50658950:G:T | W135C | 0.994 |
| 19:50658082:T:C | F119L | 0.993 |
| 19:50658084:T:A | F119L | 0.993 |
| 19:50658084:T:G | F119L | 0.993 |
| 19:50656296:T:C | F71L | 0.992 |
| 19:50656298:C:A | F71L | 0.992 |
| 19:50656298:C:G | F71L | 0.992 |
| 19:50658077:T:A | I117N | 0.992 |
| 19:50658090:C:A | N121K | 0.991 |
| 19:50658090:C:G | N121K | 0.991 |
| 19:50658096:C:A | N123K | 0.991 |
| 19:50658096:C:G | N123K | 0.991 |
| 19:50658128:G:C | R134P | 0.987 |
| 19:50658077:T:C | I117T | 0.986 |
| 19:50658077:T:G | I117S | 0.985 |
| 19:50658080:G:C | R118P | 0.985 |
| 19:50658949:G:C | W135S | 0.985 |
| 19:50658988:T:C | L148S | 0.985 |
| 19:50658955:T:A | I137N | 0.984 |
| 19:50659042:A:T | D166V | 0.983 |
| 19:50656297:T:G | F71C | 0.982 |
| 19:50656297:T:C | F71S | 0.981 |
| 19:50658952:T:C | L136P | 0.978 |
| 19:50659041:G:C | D166H | 0.978 |
| 19:50659059:G:C | D172H | 0.978 |
| 19:50659060:A:T | D172V | 0.978 |
| 19:50658009:C:A | H94Q | 0.977 |
dbSNP variants (sampled 300 via entrez): RS1000525401 (19:50648096 A>G), RS1000625630 (19:50653855 G>A), RS1000641858 (19:50652573 C>T), RS1000796545 (19:50658724 C>G,T), RS1001187942 (19:50658916 A>G), RS1001235509 (19:50659290 A>G), RS1001235752 (19:50658534 G>A,C), RS1001289551 (19:50658266 G>A,C), RS1001517825 (19:50647920 C>T), RS1001972370 (19:50648647 C>A,T), RS1002024570 (19:50648520 A>C), RS1002132967 (19:50654240 T>C), RS1002200791 (19:50659783 CCCCTACA>C), RS1002447107 (19:50649939 C>T), RS1002593805 (19:50653918 G>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| decabromobiphenyl ether | affects expression | 1 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| jinfukang | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Cisplatin | decreases expression | 1 |
| Dimethyl Sulfoxide | affects expression | 1 |
| Valproic Acid | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.